Novartis Surpasses Sales Expectations in Q4 Results
Swiss pharmaceutical giant Novartis exceeded expectations with its fourth-quarter sales, marking a strong end to the year after consistently raising its full-year guidance, showcasing resilience in the evolving market landscape -
